Post-marketing Surveillance Study of GSK Biologicals' Live, Attenuated Measles, Mumps, Rubella and Varicella Vaccine, Priorix-Tetra, Following a Single Vaccine Dose Given According to Local Prescribing Information in the Philippines
Withdrawn prior to enrolment
Phase of Trial: Phase IV
Latest Information Update: 19 Jul 2013
At a glance
- Drugs MMR-varicella zoster virus vaccine (Primary)
- Indications Measles; Mumps; Rubella; Varicella zoster virus infections
- Focus Adverse reactions
- Sponsors GlaxoSmithKline
- 19 Jul 2013 Status changed from not yet recruiting to withdrawn prior to recruitment as reported by ClinicalTrials.gov.
- 01 Mar 2013 Planned initiation date changed from 1 Jan 2013 to 1 Aug 2013 as reported by ClinicalTrials.gov.
- 08 Jan 2013 New trial record